Bionano Genomics, Inc. (BNGO) vs Meihua International Medical Technologies Co., Ltd. (MHUAF)

Bionano Genomics, Inc. and Meihua International Medical Technologies Co., Ltd. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $15.4M against $4.3M — 3.6× the size. Across the 11 metrics below, Meihua International Medical Technologies Co., Ltd. leads on 8 and Bionano Genomics, Inc. on 3.

Valuation

Metric BNGO MHUAF Medical Instruments & Supplies median
P/E n/m — 30.28
P/S 0.42 — 2.49
P/B 0.41 n/m 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m n/m 14.87
EV/Sales 0.67 n/m 2.75
Earnings yield (338.71%) — 0.00%
Free cash flow yield (160.60%) 0.00% 0.59%

Profitability

Metric BNGO MHUAF Medical Instruments & Supplies median
Gross margin 47.51% — 53.60%
Operating margin (106.67%) — 1.97%
Net margin (106.58%) — 0.00%
Free cash flow margin (67.87%) 0.00% 2.36%
Return on equity (83.56%) 0.00% 0.00%
Return on assets (52.04%) 0.00% 0.00%
Return on invested capital (81.68%) 0.00% 0.13%

Growth

Metric BNGO MHUAF Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% — 8.97%
EPS growth (last fiscal year) 94.50% (54.91%) 6.51%
Revenue growth, 5-year CAGR 27.37% (7.05%) 8.85%
Net income growth, 5-year CAGR 0.00% (18.66%) 0.00%

Health

Metric BNGO MHUAF Medical Instruments & Supplies median
Debt to equity 0.11 0.05 0.10
Current ratio 2.48 8.42 2.47
Net debt to EBITDA 1.06 (0.70) 0.97

Dividend

Metric BNGO MHUAF Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric BNGO MHUAF Medical Instruments & Supplies median
Market cap 15.37m 4.25m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack